155 related articles for article (PubMed ID: 25377928)
1. Loss to follow-up in the Australian HIV Observational Database.
McManus H; Petoumenos K; Brown K; Baker D; Russell D; Read T; Smith D; Wray L; Giles M; Hoy J; Carr A; Law MG;
Antivir Ther; 2015; 20(7):731-41. PubMed ID: 25377928
[TBL] [Abstract][Full Text] [Related]
2. Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a (post-) conflict setting: A retrospective cohort study from Goma, Democratic Republic of Congo.
Akilimali PZ; Musumari PM; Kashala-Abotnes E; Kayembe PK; Lepira FB; Mutombo PB; Tylleskar T; Ali MM
PLoS One; 2017; 12(2):e0171407. PubMed ID: 28170410
[TBL] [Abstract][Full Text] [Related]
3. Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique.
Blevins M; José E; Bilhete FR; Vaz LM; Shepherd BE; Audet CM; Vermund SH; Moon TD
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):198-207. PubMed ID: 25381732
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
[TBL] [Abstract][Full Text] [Related]
5. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon.
Bekolo CE; Webster J; Batenganya M; Sume GE; Kollo B
BMC Res Notes; 2013 Dec; 6():512. PubMed ID: 24308609
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD).
Templeton DJ; Wright ST; McManus H; Lawrence C; Russell DB; Law MG; Petoumenos K;
BMC Infect Dis; 2015 Aug; 15():326. PubMed ID: 26265164
[TBL] [Abstract][Full Text] [Related]
7. Loss to follow-up in an international, multicentre observational study.
Mocroft A; Kirk O; Aldins P; Chies A; Blaxhult A; Chentsova N; Vetter N; Dabis F; Gatell J; Lundgren JD;
HIV Med; 2008 May; 9(5):261-9. PubMed ID: 18400074
[TBL] [Abstract][Full Text] [Related]
8. Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa.
Marazzi MC; De Luca S; Palombi L; Scarcella P; Ciccacci F; Ceffa S; Nielsen-Saines K; De Luca A; Mancinelli S; Gennaro E; Zimba I; Liotta G; Buonomo E
Pediatr Infect Dis J; 2014 Mar; 33(3):295-300. PubMed ID: 23799517
[TBL] [Abstract][Full Text] [Related]
9. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
[TBL] [Abstract][Full Text] [Related]
10. Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD).
Jiamsakul A; Kiertiburanakul S; Ng OT; Chaiwarith R; Wong W; Ditangco R; Nguyen KV; Avihingsanon A; Pujari S; Do CD; Lee MP; Ly PS; Yunihastuti E; Kumarasamy N; Kamarulzaman A; Tanuma J; Zhang F; Choi JY; Kantipong P; Sim B; Ross J; Law M; Merati TP;
HIV Med; 2019 Aug; 20(7):439-449. PubMed ID: 30980495
[TBL] [Abstract][Full Text] [Related]
11. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.
Thierfelder C; Weber R; Elzi L; Furrer H; Cavassini M; Calmy A; Bernasconi E; Gutmann C; Ledergerber B;
HIV Med; 2012 Feb; 13(2):118-26. PubMed ID: 22107170
[TBL] [Abstract][Full Text] [Related]
12. Loss to follow-up and mortality rates in HIV-1-infected patients in Curaçao before and after the start of combination antiretroviral therapy.
Hermanides H; Holman R; Gras L; Winkel C; Gerstenbluth I; de Wolf F; Duits A
AIDS Res Hum Retroviruses; 2013 Oct; 29(10):1300-5. PubMed ID: 23927464
[TBL] [Abstract][Full Text] [Related]
13. Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006.
Ndiaye B; Ould-Kaci K; Salleron J; Bataille P; Bonnevie F; Choisy P; Cochonat K; Fontier C; Guerroumi H; Ajana F; Chaud P; Yazdanpanah Y
Antivir Ther; 2009; 14(4):567-75. PubMed ID: 19578242
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
[TBL] [Abstract][Full Text] [Related]
15. HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).
Han N; Wright ST; O'Connor CC; Hoy J; Ponnampalavanar S; Grotowski M; Zhao HX; Kamarulzaman A; ;
HIV Med; 2015 Mar; 16(3):152-60. PubMed ID: 25407085
[TBL] [Abstract][Full Text] [Related]
16. Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.
Mancinelli S; Nielsen-Saines K; Germano P; Guidotti G; Buonomo E; Scarcella P; Lunghi R; Sangare H; Orlando S; Liotta G; Marazzi MC; Palombi L
HIV Med; 2017 Sep; 18(8):573-579. PubMed ID: 28150466
[TBL] [Abstract][Full Text] [Related]
17. Mortality Rate in a Cohort of People Living With HIV in Rural Tanzania After Accounting for Unseen Deaths Among Those Lost to Follow-up.
Vanobberghen F; Weisser M; Kasuga B; Katende A; Battegay M; Tanner M; Glass On Behalf Of The Kiularco Study Group TR
Am J Epidemiol; 2021 Feb; 190(2):251-264. PubMed ID: 33524120
[TBL] [Abstract][Full Text] [Related]
18. Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in Tokyo.
Nishijima T; Gatanaga H; Komatsu H; Takano M; Ogane M; Ikeda K; Oka S
PLoS One; 2013; 8(8):e72310. PubMed ID: 23951307
[TBL] [Abstract][Full Text] [Related]
19. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
